Navigation Links
Researchers identify new function of protein in cellular respiration
Date:1/28/2009

RICHMOND, Va. (Jan. 28, 2009) Virginia Commonwealth University researchers have found that the protein Stat3 plays a key role in regulating mitochondria, the energy-producing machines of cells. This discovery could one day lead to the development of new treatments for heart disease to boost energy in failing heart muscle or to master the abnormal metabolism of cancer.

In the study, published online Jan. 8 in Science Express, researchers reported that Stat3, a protein previously known to control the activity of genes by acting in the cell nucleus, also plays a key role in cellular energy production.

The team examined oxygen consumption in cultured cells and hearts of mice. They discovered that when Stat 3 protein was missing, cells consumed less oxygen and produced less ATP, the key molecular form of cellular energy. The findings revealed that Stat3 is necessary for the function of the mitochondrial electron transport chain that generates ATP. Changes in energy production and expenditure are essential to maintain cellular homeostasis.

"We found evidence that Stat3 is present in the mitochondria and that it serves to control the production of ATP," said principal investigator Andrew C. Larner, M.D., Ph.D., professor of biochemistry and molecular biology in the VCU School of Medicine, and co-leader of the Immune Mechanisms research program at the VCU Massey Cancer Center.

"We have described a new pathway by which generation of ATP is regulated. This pathway could suggest new ways for Stat3 to be therapeutically manipulated to treat a variety of diseases where there are imbalances between energy generation and energy demands such as occurs in cancer and heart disease," he said.

Next, the team will conduct studies to determine the downstream targets of Stat3 in the mitochondria and identify the physiological role of Stat3 that is localized to the mitochondria in heart disease and cancer.


'/>"/>

Contact: Sathya Achia Abraham
sbachia@vcu.edu
804-827-0890
Virginia Commonwealth University
Source:Eurekalert

Page: 1

Related biology news :

1. Natural brain substance blocks weight gain in mice, UT Southwestern researchers discover
2. Researchers identify a cell type that limits stroke damage
3. Researchers iron out new role for serotonin
4. Researchers identify 4 genetic hotspots associated with psoriasis
5. Researchers genetically link Lou Gehrigs disease in humans to dog disease
6. Texas Medical Center researchers win collaborative grants
7. Researchers describe protease inhibitor that may aid in diabetic retinopathy treatment
8. Researchers examine developing hearts in chickens to find solutions for human heart abnormalities
9. JDRF-funded researchers discover proteins regulating human beta cell replication
10. Researchers to use K-States BSL-3 Lab for $1 million study of fungus threatening wheat crops
11. Researchers identify potential new weapon in battle against HIV infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... to identify and degrade the diverse types of defective ... The researchers Sabine C. Horn, Professor Thomas Sommer, Professor ... Delbrck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have ... an enzyme complex that plays a critical role in ... regulating the identification and disposal of various defectively produced ...
(Date:12/11/2009)... available in French . , Montreal, ... novel molecular mechanism that prevents cancer. In the December ... , scientists from the Universit de Montral and the ... SOCS1 molecule prevents the cancer-causing activity of cytokines, hormones ... as Crohns, in smokers and people exposed to asbestos. ...
(Date:12/11/2009)... 2009 Keystone Symposia on Molecular and Cellular ... five new Keystone Symposia Fellows for 2010. Launched ... early-career life scientists (postdoctoral trainees or assistant professors) ... for one year. Fellows are selected based on ... to promoting diversity in the biomedical and life ...
Breaking Biology News(10 mins):MDC researchers identify a scaffold regulating protein disposal 2Scientists identify natural anti-cancer defenses 2Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 2Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 3Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 4Drinking coffee slows progression of liver disease in chronic hepatitis C sufferers 59835 1Drinking coffee slows progression of liver disease in chronic hepatitis C sufferers 59835 2Happy flies look for a place like home 10440 1Happy flies look for a place like home 10440 2Researchers find ways to encourage spinal cord regeneration after injury 10437 1Researchers find ways to encourage spinal cord regeneration after injury 10437 2
... only catch fleeting glimpses of it. Up until recently, ... marine biologists and ecologists, but advances in electronic tracking ... deeper under, the surface of the oceans than ever ... giving researchers insights into the behavior and lifestyles of ...
... French . , Imagine a gigantic, inflatable, sausage-like bag ... the equivalent of 2.2 days of current global emissions. ... metres in radius and several kilometres long, resting benignly on ... , At first blush, this might appear like science fiction, ...
... Women,s & Children,s Hospital and the University of Adelaide, ... infection with high blood pressure during pregnancy and pre-term ... Journal of Obstetrics & Gynaecology, are a major step ... high blood pressure in pregnancy. , The research has ...
Other Biology News:Unveiling the underwater ways of the white shark 2Unveiling the underwater ways of the white shark 3Into the abyss: Deep-sixing carbon 2Herpes virus link to complications in pregnancy 2
(Date:12/14/2009)... -- , - Results From a ... Arthritis in Seven Major Industrialized Countries , , ... say their disease, impacts their ... living with rheumatoid arthritis find shopping for gifts, ... presents most, difficult to do, ...
(Date:12/11/2009)... (Nasdaq: DNDN ) announced today that the ... exercised in full their option to purchase an ... public offering price of $24.75 per share. ... of the offering to an aggregate of 17,250,000 ... receive net proceeds from the offering of approximately ...
(Date:12/11/2009)... a new explanation for differences in the severity of mental ... gene, the more serious the handicap. The genetic defect is ... is the amount of copies of the GDI1 gene that ... American Journal of Human Genetics , and are the result ... VIB, a life sciences research institute in Flanders, Belgium at ...
(Date:12/11/2009)... Ambit Biosciences Corporation announced today the enrollment and dosing ... Center of the first patient in the ACE ( ... fficacy) Phase 2 pivotal trial in patients with relapsed ... a novel, orally available, potent and highly selective small ... kinase-3 (FLT3) inhibitor. The ACE study is designed ...
Breaking Biology Technology:Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Amount of gene surplus determines severity of mental retardation in males 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5
... be held October 29-31 at the Palace Hotel, ... Lehrman Group, the world,s,marketplace for expertise, and the ... for the Seventh Annual BIO Investor,Forum. Featured therapeutic ... physician consultants along with executives from public and,private ...
... 24 Researchers at 28th annual,National Academy ... City this,weekend will present data to help ... breast cancer survivors affected by,"Chemobrain". Chemobrain is ... types of cancer. It is associated with ...
... Oct. 24 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. ("Angiotech") (NASDAQ: ... and medical device company, today announced that its ... place on October,30, 2008 at 8:30am Pacific time ... To listen to the meeting, please dial ...
Other Biology Technology:Gerson Lehrman Group and BIO Collaborate to Identify Scientific Expertise for the Seventh Annual BIO Investor Forum 2Gerson Lehrman Group and BIO Collaborate to Identify Scientific Expertise for the Seventh Annual BIO Investor Forum 3Brain Fitness Program Offers Hope for Breast Cancer Survivors Suffering From 'Chemobrain' 2
Many mammalian cell types and experimental situations create challenges for standard transfection experiments. The ViraPower Lentiviral Expression System overcomes these challenges with efficient vir...
Inquire...
1M stock solution (238mg/ml)...
...
Biology Products: